Acknowledgements
PATHOLOGY
We thank the patients and their families as well as the investigators and staff involved in the DAISY trial. This study was supported by Unicancer and PRecISion Medicine institute in oncology (PRISM), funded by the France 2030 program and the French National Research Agency (ANR) under grant number ANR-18-IBHU-000, and Daiichi Sankyo. We are grateful to Unicancer for promoting the clinical trial and especially to M.J. who was in charge of the DAISY clinical trial and all the members of their team that led the monitoring of the clinical data and sample shipment. We are also grateful to Daiichi Sankyo, which supported T-DXd supply to the study sites, to T. Shibutani, R. Yoshimoto and H. Takahashi for pathology experiment and support, and to N. Corcos for support with graphics.